CD98 Heavy Chain As a Prognostic Biomarker and Target for Cancer Treatment

Overview

Journal Front Oncol

Specialty Oncology

Date 2023 Oct 12

PMID 37823053

Authors

Pu Xia

Anna Dubrovska

Affiliations

Soon will be listed here.

Abstract

The SLC3A2 gene encodes for a cell-surface transmembrane protein CD98hc (4F2). CD98hc serves as a chaperone for LAT1 (SLC7A5), LAT2 (SLC7A8), yLAT1 (SLC7A7), yLAT2 (SLC7A6), xCT (SLC7A11) and Asc1 (SLC7A10) providing their recruitment to the plasma membrane. Together with the light subunits, it constitutes heterodimeric transmembrane amino acid transporters. CD98hc interacts with other surface molecules, such as extracellular matrix metalloproteinase inducer CD147 (EMMPRIN) and adhesion receptors integrins, and regulates glucose uptake. In this way, CD98hc connects the signaling pathways sustaining cell proliferation and migration, biosynthesis and antioxidant defense, energy production, and stem cell properties. This multifaceted role makes CD98hc one of the critical regulators of tumor growth, therapy resistance, and metastases. Indeed, the high expression levels of CD98hc were confirmed in various tumor tissues, including head and neck squamous cell carcinoma, glioblastoma, colon adenocarcinoma, pancreatic ductal adenocarcinoma, and others. A high expression of CD98hc has been linked to clinical prognosis and response to chemo- and radiotherapy in several types of cancer. In this mini-review, we discuss the physiological functions of CD98hc, its role in regulating tumor stemness, metastases, and therapy resistance, and the clinical significance of CD98hc as a tumor marker and therapeutic target.

Citing Articles

Different types of cell death and their interactions in myocardial ischemia-reperfusion injury.

Du B, Fu Q, Yang Q, Yang Y, Li R, Yang X Cell Death Discov. 2025; 11(1):87.

PMID: 40044643 PMC: 11883039. DOI: 10.1038/s41420-025-02372-5.

The polyamine transporter ATP13A3 mediates difluoromethylornithine-induced polyamine uptake in neuroblastoma.

Azfar M, Gao W, Van den Haute C, Xiao L, Karsa M, Pandher R Mol Oncol. 2025; 19(3):913-936.

PMID: 39981745 PMC: 11887671. DOI: 10.1002/1878-0261.13789.

Chemoresistance in Pancreatic Cancer: The Role of Adipose-Derived Mesenchymal Stem Cells and Key Resistance Genes.

Parvaneh S, Miklos V, Pahi Z, Szucs D, Monostori T, Poliska S Int J Mol Sci. 2025; 26(1.

PMID: 39796244 PMC: 11720846. DOI: 10.3390/ijms26010390.

Screening the human miRNA interactome reveals coordinated up-regulation in melanoma, adding bidirectional regulation to miRNA networks.

Jame-Chenarboo F, Reyes J, Twells N, Ng H, Macdonald D, Hernando E Sci Adv. 2025; 11(2):eadr0277.

PMID: 39792681 PMC: 11721578. DOI: 10.1126/sciadv.adr0277.

Drug Delivery Across the Blood-Brain Barrier: A New Strategy for the Treatment of Neurological Diseases.

Jiao Y, Yang L, Wang R, Song G, Fu J, Wang J Pharmaceutics. 2025; 16(12.

PMID: 39771589 PMC: 11677317. DOI: 10.3390/pharmaceutics16121611.

References

Wang X, Chen Y, Wang X, Tian H, Wang Y, Jin J . Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11. Cancer Res. 2021; 81(20):5217-5229. PMC: 8530936. DOI: 10.1158/0008-5472.CAN-21-0567. View

Friesema E, Docter R, Moerings E, Verrey F, Krenning E, Hennemann G . Thyroid hormone transport by the heterodimeric human system L amino acid transporter. Endocrinology. 2001; 142(10):4339-48. DOI: 10.1210/endo.142.10.8418. View

Karamanos N, Theocharis A, Neill T, Iozzo R . Matrix modeling and remodeling: A biological interplay regulating tissue homeostasis and diseases. Matrix Biol. 2018; 75-76:1-11. PMC: 6377817. DOI: 10.1016/j.matbio.2018.08.007. View

Bianconi D, Fabian E, Herac M, Kieler M, Thaler J, Prager G . Expression of CD98hc in Pancreatic Cancer and Its Role in Cancer Cell Behavior. J Cancer. 2022; 13(7):2271-2280. PMC: 9066202. DOI: 10.7150/jca.70500. View

Nakamura E, Sato M, Yang H, Miyagawa F, Harasaki M, Tomita K . 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer. J Biol Chem. 1999; 274(5):3009-16. DOI: 10.1074/jbc.274.5.3009. View

Cormerais Y, Pagnuzzi-Boncompagni M, Schrotter S, Giuliano S, Tambutte E, Endou H . Inhibition of the amino-acid transporter LAT1 demonstrates anti-neoplastic activity in medulloblastoma. J Cell Mol Med. 2019; 23(4):2711-2718. PMC: 6433660. DOI: 10.1111/jcmm.14176. View

Digomann D, Linge A, Dubrovska A . SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed. Autophagy. 2019; 15(10):1850-1851. PMC: 6735542. DOI: 10.1080/15548627.2019.1639302. View

Chen J, Li Y, Yu T, McKay R, Burns D, Kernie S . A restricted cell population propagates glioblastoma growth after chemotherapy. Nature. 2012; 488(7412):522-6. PMC: 3427400. DOI: 10.1038/nature11287. View

Nachef M, Ali A, Almutairi S, Lee S . Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment. Front Immunol. 2021; 12:624324. PMC: 8089370. DOI: 10.3389/fimmu.2021.624324. View

10.

Keriel A, Botella E, Estrach S, Bragagnolo G, Vergunst A, Feral C . Brucella Intracellular Life Relies on the Transmembrane Protein CD98 Heavy Chain. J Infect Dis. 2014; 211(11):1769-78. DOI: 10.1093/infdis/jiu673. View

11.

Geng J, Chen R, Yang F, Lin P, Zhu Y, Fu X . CD98-induced CD147 signaling stabilizes the Foxp3 protein to maintain tissue homeostasis. Cell Mol Immunol. 2021; 18(12):2618-2631. PMC: 8632965. DOI: 10.1038/s41423-021-00785-7. View

12.

Gupta S, Singh S, Popovici J, Roesch C, Shakri A, Guillotte-Blisnick M . Targeting a Reticulocyte Binding Protein and Duffy Binding Protein to Inhibit Reticulocyte Invasion by Plasmodium vivax. Sci Rep. 2018; 8(1):10511. PMC: 6043553. DOI: 10.1038/s41598-018-28757-4. View

13.

Nozaki S, Nakatani Y, Mawatari A, Shibata N, Hume W, Hayashinaka E . F-FIMP: a LAT1-specific PET probe for discrimination between tumor tissue and inflammation. Sci Rep. 2019; 9(1):15718. PMC: 6823354. DOI: 10.1038/s41598-019-52270-x. View

14.

Martens-de Kemp S, Brink A, Stigter-van Walsum M, Damen J, Rustenburg F, Wu T . CD98 marks a subpopulation of head and neck squamous cell carcinoma cells with stem cell properties. Stem Cell Res. 2013; 10(3):477-88. DOI: 10.1016/j.scr.2013.02.004. View

15.

Adyns L, Proost P, Struyf S . Role of Defensins in Tumor Biology. Int J Mol Sci. 2023; 24(6). PMC: 10049535. DOI: 10.3390/ijms24065268. View

16.

Liu Z, Hou J, Chen J, Tsumura H, Ito M, Ito Y . Deletion of CD98 heavy chain in T cells results in cardiac allograft acceptance by increasing regulatory T cells. Transplantation. 2012; 93(11):1116-24. DOI: 10.1097/TP.0b013e31824fd7cd. View

17.

Xu X, Zhang X, Wei C, Zheng D, Lu X, Yang Y . Targeting SLC7A11 specifically suppresses the progression of colorectal cancer stem cells via inducing ferroptosis. Eur J Pharm Sci. 2020; 152:105450. DOI: 10.1016/j.ejps.2020.105450. View

18.

Fagerberg L, Hallstrom B, Oksvold P, Kampf C, Djureinovic D, Odeberg J . Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics. 2013; 13(2):397-406. PMC: 3916642. DOI: 10.1074/mcp.M113.035600. View

19.

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

20.

Digomann D, Kurth I, Tyutyunnykova A, Chen O, Lock S, Gorodetska I . The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity. Clin Cancer Res. 2019; 25(10):3152-3163. DOI: 10.1158/1078-0432.CCR-18-2951. View